GPC3-targeted immunoPET imaging of hepatocellular carcinomas.
Shuxian AnDi ZhangYou ZhangCheng WangLiang ShiWeijun WeiGang HuangJianjun LiuPublished in: European journal of nuclear medicine and molecular imaging (2022)
In the work, we successfully developed sdAb-derived GPC3-targeted immunoPET imaging strategies and characterized the superior diagnostic accuracies in preclinical HCC models. Furthermore, we synthesized a fusion protein ABDG2 with improved targeting and pharmacokinetic properties, serving as a promising candidate for developing radioimmunotherapy agents.